Skip to content
2000
Volume 19, Issue 13
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Evidence-based review of the existing literature ultimately recommends stocking of Methylene Blue (MB) as an emergency antidote in the United States. The same is reported around the world in Japan, Greece, Italy and Canada. The observation that MB is always present as the main antidote required in emergency and critical care units calls for a revisit on its effects on the NO/cGMP system to reemphasize its multisystem actions. Therefore, the present review aimed to display the role of MB in emergency units, concerning: 1) Polytrauma and circulatory shock; 2) Neuroprotection, 3) Anaphylaxis and, 4) Overdose and poisoning.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/1389450119666180403100410
2018-10-01
2025-08-14
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/1389450119666180403100410
Loading

  • Article Type:
    Review Article
Keyword(s): anaphylaxis; cGMP; circulatory shock; Methylene blue; neuroprotection; nitric oxide; poisoning
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test